Insiders Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-08 EDT			5-day change	1st Jan Change
418.8 ^USD	+2.09%		+4.15%	+2.93%

05-07	FOMO is Back
05-07	ANALYST RECOMMENDATIONS : Nvidia, The Home Depot, Lowe's, Rollins...

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vertex Pharmaceuticals Insider Sold Shares Worth $2,142,974, According to a Recent SEC Filing	02-27	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $506,546, According to a Recent SEC Filing	02-23	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $1,519,637, According to a Recent SEC Filing	02-23	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $3,776,528, According to a Recent SEC Filing	02-16	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $727,822, According to a Recent SEC Filing	02-13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $1,804,931, According to a Recent SEC Filing	02-13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $383,679, According to a Recent SEC Filing	02-13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $1,321,655, According to a Recent SEC Filing	02-13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $577,410, According to a Recent SEC Filing	02-13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $2,785,977, According to a Recent SEC Filing	01-10	MT
Shield Therapeutics hires former Akili leader as new CFO	01-09	AN
Vertex Pharmaceuticals Insider Sold Shares Worth $1,215,000, According to a Recent SEC Filing	01-04	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $6,973,945, According to a Recent SEC Filing	12-19	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $5,333,799, According to a Recent SEC Filing	12-15	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $2,023,906, According to a Recent SEC Filing	12-15	MT
Vertex Pharmaceuticals Incorporated Appoints Nancy Thornberry to Its Board of Directors as an Independent Director	12-05	CI
Vertex Pharmaceuticals Insider Sold Shares Worth $2,151,633, According to a Recent SEC Filing	11-16	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $1,921,569, According to a Recent SEC Filing	11-15	MT
Vertex Pharmaceuticals Inc / Ma Insider Sold Shares Worth $4,331,250, According to a Recent SEC Filing	11-08	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $2,011,304, According to a Recent SEC Filing	11-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease

December 11, 2023 at 05:47 am